Skin cancer and COVID-19: was the diagnosis safeguarded by teledermatology? a study on 1229 cases

J Eur Acad Dermatol Venereol. 2022 Aug;36(8):e615-e617. doi: 10.1111/jdv.18138. Epub 2022 Apr 26.

Authors

C Skayem^{1

2}, C Hua², O Zehou², A Jannic², A Viarnaud², P Wolkenstein², T A Duong^{3

4}

Affiliations

¹ Faculty of Medicine, Sorbonne University, Paris, France.
² Assistance Publique des Hôpitaux de Paris (AP-HP), Henri Mondor Hospital, Paris, France.
³ Chaire Avenir Santé Numérique, Equipe 8 IMRB, Inserm, Université Paris Est Créteil, Paris, France.
⁴ Department of Telemedicine, Assistance Publique des Hôpitaux de Paris (AP-HP), Hôpital Université Paris-Saclay, Paris, France.

No abstract available

Publication types

Letter

MeSH terms

COVID-19*
Dermatology*
Humans
Skin Diseases*
Skin Neoplasms* / diagnosis
Telemedicine*